275 related articles for article (PubMed ID: 679156)
1. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
Jubert AV; Talbott TM; Maycroft TM
Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
[TBL] [Abstract][Full Text] [Related]
2. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer.
Onetto M; Paganuzzi M; Secco GB; Fardelli R; Santi F; Rovida S; Ferrara GB
Biomed Pharmacother; 1985; 39(7):392-5. PubMed ID: 3830268
[TBL] [Abstract][Full Text] [Related]
3. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.
Goslin R; Steele G; Macintyre J; Mayer R; Sugarbaker P; Cleghorn K; Wilson R; Zamcheck N
Ann Surg; 1980 Dec; 192(6):747-51. PubMed ID: 7447529
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
Boey J; Cheung HC; Lai CK; Wong J
World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
[No Abstract] [Full Text] [Related]
5. Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA.
Mariani G; Carmellini M; Bonaguidi F; Benelli MA; Toni MG
Eur J Cancer (1965); 1980 Aug; 16(8):1099-103. PubMed ID: 7439224
[No Abstract] [Full Text] [Related]
6. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
Koch M; Washer G; Gaedke H; McPherson TA
J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
[TBL] [Abstract][Full Text] [Related]
7. [The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma].
Hasler E; Spengler A; Berchtold R; Brunner KW; de Weck A
Schweiz Med Wochenschr; 1977 Nov; 107(47):1683-91. PubMed ID: 929129
[TBL] [Abstract][Full Text] [Related]
8. Results of CEA-initiated second-look surgery for recurrent colorectal cancer.
Steele G; Zamcheck N; Wilson R; Mayer R; Lokich J; Rau P; Maltz J
Am J Surg; 1980 Apr; 139(4):544-8. PubMed ID: 7369462
[No Abstract] [Full Text] [Related]
9. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
[TBL] [Abstract][Full Text] [Related]
10. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study.
Minton JP; Hoehn JL; Gerber DM; Horsley JS; Connolly DP; Salwan F; Fletcher WS; Cruz AB; Gatchell FG; Oviedo M
Cancer; 1985 Mar; 55(6):1284-90. PubMed ID: 3971297
[TBL] [Abstract][Full Text] [Related]
11. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
Armitage NC; Davidson A; Tsikos D; Wood CB
Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen: clinical and historical aspects.
Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
Lunde OC; Havig O
Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
[TBL] [Abstract][Full Text] [Related]
14. Serial carcinoembryonic antigen assays. Use in detection of cancer recurrence.
Sorokin JJ; Sugarbaker PH; Zamcheck N; Pisick M; Kupchik HZ; Moore FD
JAMA; 1974 Apr; 228(1):49-53. PubMed ID: 4406144
[No Abstract] [Full Text] [Related]
15. Carcinoembryonic antigen in the diagnosis and management of colorectal carcinoma. Current status.
Livingstone AS; Hampson LG; Shuster J; Gold P; Hinchey EJ
Arch Surg; 1974 Aug; 109(2):259-64. PubMed ID: 4846441
[No Abstract] [Full Text] [Related]
16. Immunohistological patterns of carcinoembryonic antigen in colorectal carcinoma. Correlation with staging and blood levels.
Pihl E; McNaughtan J; Ward HA; Nairn RC
Pathology; 1980 Jan; 12(1):7-13. PubMed ID: 7375147
[TBL] [Abstract][Full Text] [Related]
17. The usefulness and limitations of CEA assay in the management of colorectal cancer.
Tomoda H; Furusawa M
Jpn J Surg; 1981 Jan; 11(1):33-8. PubMed ID: 7311186
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
Yu BM
Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
[TBL] [Abstract][Full Text] [Related]
19. CEA levels at recurrence and metastases; importance for detecting secondary disease.
Rieger A; Wahren B
Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
[TBL] [Abstract][Full Text] [Related]
20. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables.
Tabuchi Y; Deguchi H; Imanishi K; Saitoh Y
Cancer; 1987 Apr; 59(7):1283-8. PubMed ID: 3815304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
